Christopher Kabrhel MD MPH is a practicing emergency physician, Director of the Center for Vascular Emergencies at Massachusetts General Hospital (MGH), Professor of Emergency Medicine at Harvard Medical School and the MGH Endowed Chair in Emergency Medicine. He received his M.D. from the Johns Hopkins University School of Medicine, a Masters in Public Health from the TH Chan Harvard School of Public Health (HSPH) and completed residency at the Harvard Affiliated Emergency Medicine Residency program. Dr. Kabrhel has more than 15 years of experience performing research into the epidemiology, diagnosis, risk stratification and treatment of acute venous thromboembolism. Dr. Kabrhel's research is funded by the National Institutes of Health, as well as private foundations and industry. He coordinates venous thromboembolism research for the Nurses’ Health Study at Channing Network Medicine at the Health Professionals Follow Up Study at HSPH where he focuses on genetic epidemiology and population risk factors for VTE. To further this work, he co-founded the International Network for Venous Thromboembolism research which focuses on the genetic epidemiology of VTE. In addition to epidemiology, his current work focuses on clinical risk-stratification and novel care delivery methods for patients with acute PE. In 2012, Dr. Kabrhel co-founded the MGH Pulmonary Embolism Response Team (PERT), the first such team in the world as well as the PERT Consortium, a collaboration between PERTs in the United States, South America, Europe and Asia. Dr. Kabrhel is past chair of the PERT Consortium research committee and is on the PERT Consortium Board of Directors. He is also an honorary senior lecturer at Queen Mary University of London.